← Back to Clinical Trials
Recruiting NCT07303166

NCT07303166 Qualitative Study Exploring the Determinants Involved in the Management of Osteoporosis in Frail Elderly People

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07303166
Status Recruiting
Phase
Sponsor University Hospital, Strasbourg, France
Condition Osteoporosis
Study Type OBSERVATIONAL
Enrollment 15 participants
Start Date 2024-11-15
Primary Completion 2026-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15 participants in total. It began in 2024-11-15 with a primary completion date of 2026-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aging population is associated with an increase in the number of elderly people as well as in chronic diseases, particularly osteoporosis and its fracture consequences, which lead to a decline in quality of life and life expectancy. Improved management of osteoporosis would help reduce the morbidity and mortality associated with this disease.

Eligibility Criteria

Inclusion Criteria: * Alsatian doctors treating elderly patients with osteoporosis * Who have had the opportunity to use the practical guide on osteoporosis Exclusion Criteria: \- A doctor who has never had the opportunity to use the practical guide on osteoporosis.

Contact & Investigator

Central Contact

Alexandre BOUSSUGE, MD

✉ alexandre.boussuge@chru-strasbourg.fr

📞 33 3 88 11 54 61

Frequently Asked Questions

Who can join the NCT07303166 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07303166 currently recruiting?

Yes, NCT07303166 is actively recruiting participants. Contact the research team at alexandre.boussuge@chru-strasbourg.fr for enrollment information.

Where is the NCT07303166 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07303166 clinical trial?

NCT07303166 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology